Botanicals Safety, Efficacy Evidence Levels For USP Status Created
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Pharmacopeia has adopted a resolution authorizing USP to continue setting standards for botanical products and generally mapping the organization's work over the next five years.
You may also be interested in...
Saw Palmetto "Moderate" Quality Evidence Shows BPH Symptom Relief - USP
The U.S. Pharmacopeia's final monograph on saw palmetto lists 10 published studies on the ingredient that met the USP quality standard of Level II or higher, under the organization's new criteria for evidence submission for botanicals.
Saw Palmetto "Moderate" Quality Evidence Shows BPH Symptom Relief - USP
The U.S. Pharmacopeia's final monograph on saw palmetto lists 10 published studies on the ingredient that met the USP quality standard of Level II or higher, under the organization's new criteria for evidence submission for botanicals.
Saw Palmetto "Moderate" Quality Evidence Shows BPH Symptom Relief - USP
The U.S. Pharmacopeia's final monograph on saw palmetto lists 10 published studies on the ingredient that met the USP quality standard of Level II or higher, under the organization's new criteria for evidence submission for botanicals.